Cynvenio Biosystems collects $25.5 mln
Los Angeles-based clinical diagnostics company Cynvenio Biosystems has closed $25.5 million in Series B funding. Livzon Pharmaceutical Group led the round with participation from other investors that included Greenwoods Private Equity Funds and Syno Capital.
17 June 2015•3 mins read
